Business Context and Reporting Period
Company: Mangoceuticals, Inc. (MGRX)
Filing Type: Form 8-K (Current Report)
Report Date: September 15, 2025 (Earliest Event Reported)
Signature Date: October 28, 2025
Context: The filing discloses material agreements, executive departures, and unregistered equity sales occurring between September and October 2025.
Key Financial Metrics and Agreements
Lease Agreement (Item 1.01 & 2.03):
- Term: 60 months (November 1, 2025 – October 31, 2030).
- Space: Approximately 2,467 sq. ft. of office space plus 1,253 sq. ft. of shared space in Dallas, Texas.
- Base Rent: $4,852 per month ($3,803 for premises + $966 for shared space).
- Additional Rent: Pro-rata share of taxes, insurance, and maintenance at 14.81%.
- Upfront Costs: $6,141 prepaid rent and $14,557 security deposit.
- Executive: Amanda Hammer, former Chief Operating Officer.
- Termination Date: October 22, 2025.
- Separation Payment: Nine (9) months of regular compensation paid in monthly installments starting November 1, 2025.
- Consulting: Optional future engagement at $86/hour subject to a statement of work.
- Conversion Price: $1.50 per share.
- Transaction 1 (Sept 15, 2025): Indigo Capital LP converted 500 Series B Preferred shares ($500,000 value) into 366,667 common shares.
- Transaction 2 (Oct 16, 2025): Platinum Point Capital, LLC converted 32 Series B Preferred shares ($35,200 value) into 23,466 common shares.
Material Changes vs. Prior Period
The filing does not provide comparative financial data (revenue, profit, or cash flow) against prior periods. Material changes are limited to operational and capital structure events:
- Real Estate: New long-term lease obligation replacing or supplementing prior office arrangements.
- Personnel: Termination of the Chief Operating Officer and associated employment agreement.
- Capital Structure: Reduction in Series B Convertible Preferred Stock and increase in outstanding common stock due to conversions.
Guidance, Outlook, and Risks
Management Commentary: The filing contains no forward-looking guidance, revenue outlook, or strategic commentary beyond the execution of the disclosed agreements.
Risks and Contingencies:
- Liquidity Impact: Immediate cash outflow of approximately $20,698 for lease deposits and prepaid rent, plus ongoing monthly rent obligations.
- Operational Risk: Departure of a key executive (COO), though a voluntary consulting option remains available.
- Dilution: Issuance of approximately 390,133 new common shares, though these were exchanged with existing holders under Section 3(a)(9) exemption.
Investor Verification Checklist
- Verify the total monthly cash burn impact of the new lease (Base Rent + estimated Additional Rent).
- Confirm the exact dollar value of the COO separation payment based on her regular compensation rate.
- Review the updated capitalization table to reflect the conversion of $535,200 of Series B Preferred Stock into common equity.
- Check for any subsequent filings regarding the appointment of a new Chief Operating Officer.